Search Results for keywords:"National Institutes of Health"

The National Human Genome Research Institute is holding a closed meeting of the Board of Scientific Counselors on April 28, 2025. The meeting will take place virtually from 3:00 p.m. to 6:15 p.m. and will focus on reviewing and evaluating the qualifications and performance of personnel and investigators. This meeting is private to protect the privacy of individuals being assessed. The contact person for the meeting is Shawn M. Burgess, who can be reached at the National Institutes of Health.

The National Library of Medicine is holding a closed meeting of the Biomedical Informatics, Library, and Data Sciences Review Committee on February 27-28, 2025. The meeting will be virtual and is closed to the public because it will involve discussion of confidential grant applications, which could reveal trade secrets or personal information. The purpose of the meeting is to review and evaluate these grant applications. For more details, interested parties can contact Zoe E. Huang, the Chief Scientific Review Officer.

The National Institute of General Medical Sciences is holding a meeting to review grant applications for the Centers of Biomedical Research Excellence (COBRE) Phase III Translational Centers. This meeting will take place on March 18-19, 2025, from 10:00 a.m. to 5:00 p.m., and will be conducted virtually. The meeting is closed to the public to protect confidential information and personal privacy. For more information, Dr. Manas Chattopadhyay can be contacted via email.

The National Institute of Nursing Research has announced a closed meeting scheduled for April 15, 2025. The meeting will take place virtually from 10:00 a.m. to 12:00 p.m., focusing on the review and evaluation of grant applications. Due to the sensitive nature of the discussions, which may involve confidential information or personal privacy issues, the meeting will not be open to the public. For more information, individuals can contact Dr. Weiqun Li at the National Institutes of Health.

The National Cancer Institute has announced a closed meeting to take place on May 9, 2025. This meeting, part of the Federal Advisory Committee Act, will review and evaluate contract proposals and will be held virtually. Confidentiality will be maintained to protect sensitive trade secrets and personal privacy. The session will run from 9:00 a.m. to 6:00 p.m., and any inquiries can be directed to Shamala K. Srinivas, Ph.D.

The Center for Scientific Review at the National Institutes of Health (NIH) announced a series of closed meetings to evaluate grant applications. These meetings are closed to protect confidential information about trade secrets, commercial property, and personal privacy. The meetings, held virtually, cover various topics such as membrane biology, psychosocial development, molecular neuroscience, and language and communication studies. Each meeting is managed by a designated Scientific Review Officer who can be contacted for further information.

The National Institute on Aging will hold a closed meeting on February 24, 2025, to review and evaluate grant proposals. The session, organized by the National Institutes of Health, will take place virtually and will discuss details that include confidential trade secrets and personal information. Due to these sensitive topics, the meeting is closed to the public to protect against unwarranted invasion of privacy. Dr. Kaitlyn Noel Lewis Hardell is the contact person for this event.

The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed meeting on March 24, 2021, to discuss grant applications for the advancement of cell replacement therapies for Type 1 Diabetes. This meeting is not open to the public to protect confidential information, including trade secrets and personal privacy. The meeting will be conducted via teleconference from the National Institutes of Health in Bethesda, Maryland. Dr. Ann A. Jerkins is the contact person for this meeting.

The National Heart, Lung, and Blood Institute is holding a closed meeting of the Heart, Lung, and Blood Initial Review Group's Clinical Trials Review Study Section on April 22, 2025. The meeting will run from 9:00 a.m. to 6:00 p.m. and will be conducted virtually. The purpose of the meeting is to review and evaluate grant applications, which will involve confidential discussions concerning trade secrets, commercial property, and personal information. To protect this sensitive information, the meeting is closed to the public.

In accordance with the Federal Advisory Committee Act, the National Institutes of Health (NIH) announced that several meetings of the Center for Scientific Review will be held virtually. These meetings, taking place between March 19 and March 24, 2021, are closed to the public due to the sensitive nature of the discussions, which include evaluating grant applications and potential disclosure of confidential materials. The subject matter of the meetings ranges from drug discovery and neurodegenerative disorders to HIV/AIDS prevention and treatment, with various scientific review officers assigned to manage the sessions. These sessions aim to review and evaluate various grant proposals, ensuring that personal privacy and proprietary information remain protected.